17/01/2017
EU approval of Suliqua™ triggers USD 10 million milestone payment to Zealand
Zealand Pharma (Zealand) today announced a USD 10 million milestone payment following Sanofi’s announcement of European Commission (EC) marketing authorization in Europe for Suliqua™, the once-daily titratable [...]
